Recently on Axinn Viewpoints –April 23, 2024

Vanda Strikes Out at the Supreme Court.? Two weeks ago we discussed Vanda Pharmaceuticals’ ambitious cert petition?asking the Supreme Court to discontinue the “reasonable expectation of success” standard for patent obviousness that?for decades?has been a mainstay of patent...?Read more.?

Want To Be an Antitrust Scholar? Meet the ABA’s International Scholar-in-Residence.? Many practitioners wonder what it would be like to be an academic, diving deeply into the leading international legal and policy issues at the forefront of antitrust and competition law.? On this episode of Our Curious Amalgam, Axinn managing...?Read more.?

USITC Commissioner Series: Top Dissenting Issues.? This is part three of our USITC Commissioner Series.? Read part one here and part two here.? Following my colleagues’ efforts in this series, this post examines the dissent/concurrence practice of the Commissioners at the U.S....?Read more.?

Step Aside, FTC: NYC to Banish Non-Competes.? The FTC's proposed ban on labor non-competes has loomed since January 2023, with a vote now scheduled for April 23, 2024 in a special Open Commission Meeting. New York City recently joined the growing number of states that are seeking to enact...?Read more.?

USITC Commissioner Series: Meet the (Vocal) Commissioners.? This is part two of our USITC Commissioner Series. Read part one here and part three here.? As my colleagues Brian Johnson and Ian Swan reported in March, dissenting and concurring opinions in Section 337 Investigations, either as footnotes...?Read more.?